Ching-Chung Chang MD , Shao-Wei Lo MD , Hua-Ching Chang MD , Junmin Song MD, MS , Yu-Cheng Chang MD , Kevin Yang MD , Kuan-Yu Chi MD , Yu Chang MD , Cho-Hung Chiang MD , Cho-Han Chiang MD, MMSc
{"title":"在黑色素瘤患者中,CTLA-4抑制剂比PD-1抑制剂与更高的心血管事件风险相关。","authors":"Ching-Chung Chang MD , Shao-Wei Lo MD , Hua-Ching Chang MD , Junmin Song MD, MS , Yu-Cheng Chang MD , Kevin Yang MD , Kuan-Yu Chi MD , Yu Chang MD , Cho-Hung Chiang MD , Cho-Han Chiang MD, MMSc","doi":"10.1016/j.jaad.2025.02.074","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":"93 1","pages":"Pages 202-204"},"PeriodicalIF":11.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanoma\",\"authors\":\"Ching-Chung Chang MD , Shao-Wei Lo MD , Hua-Ching Chang MD , Junmin Song MD, MS , Yu-Cheng Chang MD , Kevin Yang MD , Kuan-Yu Chi MD , Yu Chang MD , Cho-Hung Chiang MD , Cho-Han Chiang MD, MMSc\",\"doi\":\"10.1016/j.jaad.2025.02.074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17198,\"journal\":{\"name\":\"Journal of the American Academy of Dermatology\",\"volume\":\"93 1\",\"pages\":\"Pages 202-204\"},\"PeriodicalIF\":11.8000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Academy of Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0190962225003706\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0190962225003706","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanoma
期刊介绍:
The Journal of the American Academy of Dermatology (JAAD) is the official scientific publication of the American Academy of Dermatology (AAD). Its primary goal is to cater to the educational requirements of the dermatology community. Being the top journal in the field, JAAD publishes original articles that have undergone peer review. These articles primarily focus on clinical, investigative, and population-based studies related to dermatology. Another key area of emphasis is research on healthcare delivery and quality of care. JAAD also highlights high-quality, cost-effective, and innovative treatments within the field. In addition to this, the journal covers new diagnostic techniques and various other topics relevant to the prevention, diagnosis, and treatment of skin, hair, and nail disorders.